Cambridge-based Camena secures €9.2 million to cope with increased demand for DNA “writing”

Published on July 3, 2023

Synthetic genes are widely used by researchers to understand the mechanisms of disease, and in the drug discovery process to combat them. However, the cost, time and accuracy of traditional DNA synthesis methods developed in the 1980s remain problematic, particularly when creating long or complex sequences of genes. Camena Bioscience, a synthetic biology company that…

This content is for members only. Visit the site and log in/register to read.

The post Cambridge-based Camena secures €9.2 million to cope with increased demand for DNA “writing” appeared first on EU-Startups.

Continue reading on website
Other news

6 hurdles startups face when seeking investors – and how to overcome them (Sponsored)

July 3, 2023
Finding your first investors is a make-or-break moment for startups, but it is not such an easy task. Drawing on the expertise of EIT Health, one of Europe’s largest healthcare innovation networks, we delve into the top obstacles that startups face during this pivotal stage, from dispelling misconceptions to finding the right investors instead of… This content is for members only. Visit the site a

Munich-based Quantum Systems partners with Airbus Defence and Space in a research effort on AI

July 3, 2023
The Planning Office of the German Armed Forces has awarded Airbus Defence and Space GmbH, Quantum-Systems GmbH and Spleenlab GmbH with a research endeavor to demonstrate and analyze the AI building blocks required for swarms of tactical UAS in a real-world scenario. The project, titled KITU 2 (Künstliche Intelligenz für taktische UAS; Artificial Intelligence for… This content is for members only.